Talus Bio

Discovering drugs that target the DNA regulome

·Health & Fitness·YC Summer 2021·tracked since Sep 25, 2026
WatchVisit site ↗
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders

About Talus Bio

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Discover more startups

Browse the board →